Key Dates

Related Announcements

PA-21-151 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Issued by

National Institute of General Medical Sciences (NIGMS)

Purpose

This Notice of Special Interest (NOSI) encourages applications for support of conferences focused on evidence-informed interventions to enhance training, workforce development and diversity in the biomedical research enterprise. 

Background

The dissemination of knowledge through conferences stimulates hypothesis-driven inquiry into evidence-informed approaches in biomedical research education and training, workforce development, and diversity. Conferences represent a valuable opportunity for practitioners, researchers, and other consumers of evidence-informed approaches to interact, collaborate, share experiences and solutions, and to learn from experts within, across, and outside their professional fields.

Areas of Interest

NIGMS encourages applications that propose a conference* that focuses on training, workforce development, and diversity, for example by:

• Offering opportunities to foster cross-institutional collaborations through learning and networking and to advance evidence-informed practices in the management and administration of NIGMS training programs.
• Bringing together a community for discussion of innovations in theoretical paradigms, methodologies, tools, and approaches that have practical implications in the design of programs that intervene to improve student, trainee, faculty, administrator, and institutional climate and outcomes.
• Convening individuals who are at the forefront of the development, administration, and implementation of research training, mentor training, leadership development and career transition efforts, and institution and institutional climate transformations.
• Highlighting interventions that are feasible, adaptable, scalable, sustainable, and disseminable to the biomedical research enterprise.

*Please see NIGMS' Support for Scientific Meetings for additional information and restrictions.

Potential applicants are strongly encouraged to discuss the scientific meeting purpose, goals, themes, and topics for potential responsiveness to this NOSI with the contact listed below. Note: A discussion with the listed contact does not replace the required Permission to Submit letter.  

Application and Submission Information

This NOSI applies to the due date of April 12, 2023.

Submit applications for this initiative using the following funding opportunity announcement (FOA).

• PA-21-151 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:

• For funding consideration, applicants must include “NOT-GM-23-028” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.

Applications nonresponsive to terms of this NOSI will not be considered for the NOSI initiative.

Inquiries

Michael Sesma, Ph.D.
Division of Training, Workforce Development and Diversity
National Institute of General Medical Sciences
Email: [email protected]

Edgardo Falc n-Morales, Ph.D.
Division of Training, Workforce Development and Diversity
National Institute of General Medical Sciences
Email: [email protected]

Mercedes Rubio, Ph.D.
Division of Training, Workforce Development and Diversity
National Institute of General Medical Sciences
Email: [email protected]